Any current/future new fundraising through debt or equity?

The company plans to raise more long-term debt for new projects, partly funded through internal accruals. Interest costs may increase in the next year due to this additional debt. Currently, the company is debt-free with excess cash, which will be deployed for new CAPEX projects. No explicit mention or indication of any immediate equity fundraising during the call. Expansion projects are ongoing with investments being made, but financing is primarily via debt and internal funds.

Any current/future capex/capital investment/strategic investment?

The company has ongoing expansion projects expected to complete by end of FY 2026-27 (March-April 2027). These projects include 3-4 different initiatives starting commissioning gradually from end of current year to April next year. Expected revenue addition from these expansions is around Rs. 550 to 600 crores (not Rs. 200 crores as earlier mentioned). Investment cycle has already started with planning and long-lead item purchase orders completed. New capacity expansion, especially in nitrile latex, is under consideration but not justified currently due to global overcapacity; potential expans

Future growth expectations in sales/revenue/volumes?

The company expects to continue growing beyond the current year but does not anticipate reaching Rs. 2000 crores turnover by FY 2026-27 due to limited capacity and current price levels. Total volumes have grown 10% YoY this quarter and 15% YoY for the nine months, indicating ongoing volume-led growth. Export volumes are up 21% YoY, reflecting strong performance in international markets. Capacity utilization for nitrile latex is around 70-75% with potential to reach full utilization next year, indicating room for volume growth before new capacity is required. New capacity expansions are

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects growth beyond the current year but is unlikely to reach Rs. 2000 crores turnover by FY 2026-27 due to capacity constraints and current price levels. EBITDA margins have expanded to around 13%, with potential to increase to 16% as volumes rise and operational efficiencies improve. Utilization rates are high (NBR at 100%, nitrile latex around 70-75%), with roughly one year of growth left before new capacity is needed. New capacity expansions, especially for nitrile latex, are not anticipated in the next 1-2 years due to margin pressures and global overcapacity. Profit after t

IN US

Sale is live|00:00:00left today

Apcotex Industries LtdQ4 FY27Industrial Products

Apcotex Industries Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹534P/E: 25.1Market Cap: ₹2.5K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→The company expects to continue growing beyond the current year but does not anticipate reaching Rs. 2000 crores turnover by FY 2026-27 due to limited capacity and current price levels.
→Total volumes have grown 10% YoY this quarter and 15% YoY for the nine months, indicating ongoing volume-led growth.
→Export volumes are up 21% YoY, reflecting strong performance in international markets.
→Capacity utilization for nitrile latex is around 70-75% with potential to reach full utilization next year, indicating room for volume growth before new capacity is required.
→New capacity expansions are planned but unlikely in the next 1-2 years, particularly for nitrile latex, where capacity can be expanded by 50-60% if market conditions justify it.
→Operating revenue is broadly stable YoY, but volume and margin improvements are expected to drive EBITDA and PAT growth going forward.
→Growth focus remains on volume increase, margin expansion, and operational efficiency rather than aggressive top-line targets.

Margin guidance

Category 3

→The company expects growth beyond the current year but is unlikely to reach Rs. 2000 crores turnover by FY 2026-27 due to capacity constraints and current price levels.
→EBITDA margins have expanded to around 13%, with potential to increase to 16% as volumes rise and operational efficiencies improve.
→Utilization rates are high (NBR at 100%, nitrile latex around 70-75%), with roughly one year of growth left before new capacity is needed.
→New capacity expansions, especially for nitrile latex, are not anticipated in the next 1-2 years due to margin pressures and global overcapacity.
→Profit after tax (PAT) rose 79% YoY for nine months, reflecting strong operational performance.
→Working capital pressures may increase with rising raw material prices, but overall cash generation remains strong.
→ROCE will remain a key focus; even if EBITDA percentage margins fluctuate due to raw material price volatility, overall returns are expected to stay healthy.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→The company plans to raise more long-term debt for new projects, partly funded through internal accruals.
→Interest costs may increase in the next year due to this additional debt.
→Currently, the company is debt-free with excess cash, which will be deployed for new CAPEX projects.
→No explicit mention or indication of any immediate equity fundraising during the call.
→Expansion projects are ongoing with investments being made, but financing is primarily via debt and internal funds.

Order book

The transcript does not provide specific details on the current or expected order book or pending orders. However, some relevant points related to business outlook and capacity utilization are: - The company is operating at high capacity utilization across product lines: NBR at 100%, nitrile latex around 70-75%, other synthetic latex products around 85-87%. - New capacity expansions expected by FY’27 aim to support future growth. - Volume growth has been strong (10-15% year-on-year) with highest-ever export volumes up 21% Y-O-Y. - Utilization improvements and capacity constraints suggest strong demand. - Company is focusing on volume-led growth and margin expansion but did not disclose explicit order book details. - No direct mention of order backlog or pending order quantities is made in the provided text.

Capex plans

Yes

→The company has ongoing expansion projects expected to complete by end of FY 2026-27 (March-April 2027).
→These projects include 3-4 different initiatives starting commissioning gradually from end of current year to April next year.
→Expected revenue addition from these expansions is around Rs. 550 to 600 crores (not Rs. 200 crores as earlier mentioned).
→Investment cycle has already started with planning and long-lead item purchase orders completed.
→New capacity expansion, especially in nitrile latex, is under consideration but not justified currently due to global overcapacity; potential expansion by 50-60% when warranted, with about 9-10 months lead time after decision.
→The company will raise some long-term debt along with internal accruals to fund these new CAPEX projects.
→There is an investment (~Rs. 3.5 crore) ongoing in a wind energy project in Gujarat; credits expected to start early next year.

How does Apcotex Industries Ltd rank vs peers in Industrial Products?

Pro feature

1Apcotex Industries Ltd

Rev 3Mar 3

See full Industrial Products sector rankings

Want more stocks like Apcotex Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio